The authors reply

Kidney Int. 2013 Jun;83(6):1201-2. doi: 10.1038/ki.2013.42.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Antineoplastic Agents*
  • Apoptosis / drug effects*
  • Cilastatin / pharmacology*
  • Cisplatin*
  • Kidney / drug effects*
  • Kidney Diseases / prevention & control*
  • Male
  • Protease Inhibitors / pharmacology*

Substances

  • Antineoplastic Agents
  • Protease Inhibitors
  • Cilastatin
  • Cisplatin